BILLERICA, Mass.--(BUSINESS WIRE)--
Insulet Corporation (NASDAQ: PODD) (Insulet), the leader in tubeless
insulin pump technology with its Omnipod® Insulin
Management System, today announced that management will present at the
Jefferies 2017 London Healthcare Conference on November 15, 2017, at
9:20am local London time.
This press release features multimedia. View the full release here:
To listen to a live audio webcast of the presentation, please visit http://investors.insulet.com/.
A replay of the webcast will also be available following the event.
About Insulet Corporation:
Insulet Corporation is an innovative medical device company dedicated to
making the lives of people with diabetes easier. Insulet seeks to expand
the use of insulin pump therapy with its Omnipod Insulin Management
System among people with insulin-dependent diabetes. The Omnipod System
is a revolutionary and easy-to-use tubeless insulin pump that provides
up to three days of non-stop insulin delivery, without the need to see
or handle a needle. Insulet's Delivery Systems business partners with
global pharmaceutical and biotechnology companies to adapt the Omnipod
technology platform for the delivery of subcutaneous drugs across
multiple therapeutic areas. Founded in 2000, Insulet Corporation is
based in Billerica, Massachusetts. For more information, please visit: http://www.myomnipod.com.
View source version on businesswire.com: http://www.businesswire.com/news/home/20171113005071/en/
Investor Relations and Media Contact:
Deborah R. Gordon, 978-600-7717
Investor Relations and Corporate Communications
Source: Insulet Corporation
News Provided by Acquire Media